AAMC Home   Tomorrow's Doctors Tomorrow's Cures
  Home  Government Affairs   Newsroom   Meetings   Publications Shopping Cart   Site Map    

Washington Highlights: December 8, 2006

AAMC and Hospital Groups Urge Congress to Prevent Medicaid Cuts

AAMC President Darrell Kirch, M.D., American Hospital Association Executive Vice President Rick Pollack, and National Association of Public Hospitals and Health Systems President Larry Gage co-signed a Dec. 4 letter to current and incoming congressional leaders expressing "concern with the administration's plan to cut the Medicaid program through the regulatory process." The letter warns that "the administration plans to move forward" and cut $12.2 billion in FY 2007 Medicaid funding [see Washington Highlights, Feb. 10]. It urges the members to "prevent CMS from proceeding with the implementation of these rules."

In the Senate, the letter was sent to: Majority Leader Bill Frist (R-Tenn.); incoming Majority Leader Harry Reid (D-Nev.); incoming Assistant Majority Leader Dick Durbin (D-Ill.); incoming Minority Leader Mitch McConnell (R-Ky.); Finance Committee Chairman Charles Grassley (R-Iowa); and incoming Finance Committee Chairman Max Baucus (D-Mont.). In the House, the letter was delivered to: Speaker Dennis Hastert (R-Ill.); incoming Speaker Nancy Pelosi (D-Calif.); House Majority Leader John Boehner (R-Ohio); incoming House Majority Leader Steny Hoyer (D-Md.); House Majority Whip Roy Blunt (R-Mo.); Energy and Commerce Committee Chairman Joe Barton (R-Texas); and incoming Energy and Commerce Committee Chairman John Dingell (D-Mich.).

Information:
Christiane Mitchell, Senior Legislative Analyst
AAMC Government Relations
cmitchell@aamc.org
(202) 828-0526

Congress to Pass Third Funding Extension

The House and Senate must approve a third stopgap funding measure before they adjourn for the end of the 109th Congress. Both chambers are expected to pass a continuing resolution (CR) to keep federal programs running through Feb. 15, 2007.

Congress must pass another CR to provide funds for federal programs in the nine FY 2007 spending bills that have not-yet been enacted. These programs are currently funded under a CR that expires Dec. 8. The CR includes the Labor-HHS-Education bill (H.R. 5647, S. 3708). Programs in the Labor-HHS-Education bill will continue to be funded at the FY 2006 level.

Information:
Dave Moore, Senior Director
AAMC Government Relations
dbmoore@aamc.org
(202) 828-0525

AAMC, HPNEC Urge Title VII Restoration

The AAMC, along with 60 national health and education organizations, Dec. 6 urged Congress to restore funding for the Title VII health professions programs to FY 2005 levels. The Health Professions and Nursing Education Coalition (HPNEC) letter, sent to all Members of Congress, states, "it is essential that Congress reverse the enacted cuts to the health professions programs to help resolve systemic workforce shortages and deliver care to our nation's most vulnerable communities."

The final appropriation for FY 2006 cut funding for Title VII programs by 51.5 percent, resulting in the elimination or drastic reduction of grant programs including the Health Careers Opportunity Program, Centers of Excellence, primary care training, geriatric education, and rural training. Neither the House nor Senate Labor-HHS-Education Appropriations bills for FY 2007 (HR 5647, S 3708) fully restore funding for the health professions programs. With expected passage of another continuing resolution to Feb. 15, 2007, the programs will continue to be funded at FY 2006 levels until the FY 2007 budget is finalized (see related story).

Information:
Erica Froyd, Director, Public Health and Research Legislative Affairs
AAMC Government Relations
efroyd@aamc.org
(202) 828-0525

Tannaz Rasouli, Senior Legislative Analyst
AAMC Government Relations
trasouli@aamc.org
(202) 828-0525

Senate May Consider NIH Bill

At press time, it is unclear whether the Senate will take up a revised National Institutes of Health (NIH) reauthorization bill that resulted from extensive negotiations between House Energy and Commerce Chair Joe Barton (R-Texas) and members of the Senate appropriations and authorizing committees. Senator Mike Enzi (R-Wyo.), chair of the Health, Education, Labor and Pensions Committee reportedly "hotlined" the bill Dec. 6, relinquishing his committee's jurisdiction over the legislation and making it eligible for Senate approval.

The revised bill increases the authorization levels for NIH to $30.3 billion in FY 2007 and $32.8 billion in FY 2008, which represent increases of 7 percent and 8.2 percent respectively. The bill also authorizes "such sums as may be necessary" for FY 2009. The House passed bill authorized 5 percent increases each year for FYs 2007 through 2009, peaking at $32.8 billion in FY 2009.

The revised bill also eliminates the formula included in the House passed bill to direct half of all new dollars for NIH to the "common fund." The new bill requires the Director of NIH to establish a reserve account to fund the common fund, subject to appropriations. The revised bill also clarifies that the amount reserved for the common fund may not be less than the percentage reserved during the previous fiscal year and requires a report to Congress every two years, beginning June 1, 2007, outlining the strategic plan for funding research through the common fund.

The new bill also clarifies that certain recommendations regarding the organizational structure of the NIH made by the Scientific Management Review Board are subject to congressional review prior to implementation.

The House passed the "National Institutes of Health Reform Act of 2006" (H.R. 6164) Sept. 26 [see Washington Highlights, Sept. 29]. The House is expected to approve the revised bill before it adjourns, clearing the measure for the President.

Information:
Dave Moore, Senior Director
AAMC Government Relations
dbmoore@aamc.org
(202) 828-0525

VA Plans to Increase GME Positions

The Department of Veterans Affairs (VA) plans to increase support for medical residency positions starting in the 2007-2008 academic year (AY). The graduate medical education (GME) enhancement initiative stems from the recommendations included in the September 2005 Advisory Committee on Veterans Health Administration Resident Education report. The report encouraged the VA to restore and maintain its historic support for 11 percent of the total U.S. resident physician positions. In recent years, the VA has averaged only 9 percent of the national total.

VA anticipates adding 2000 resident positions over the next 5 years at a rate of 300 to 500 positions annually. The VA reports that it has approved funding for Phase I (AY 2007-08) and approved initiation of Phase II (AY 2008-09). In the first round of the GME enhancement initiative, 341 new positions will be added across the country in July 2007. The next request for proposals will be issued in spring 2008.

According to Malcolm Cox, M.D., VA Chief Academic Affiliations Officer, "These positions will not only address VA's critical needs and the looming U.S. physician workforce shortage, but will also provide flexibility in training in new specialties and new sites of care, such as community-based clinics. The availability of additional physician resident positions will also encourage innovation in education that is patient-centered and inter-professional in nature and that incorporates state-of-the-art models of clinical care, including VA's renowned quality and patient safety programs and electronic medical record system."

Information:
Matthew Shick, Senior Legislative Analyst
AAMC Government Relations
mshick@aamc.org
(202) 862-6116

Senate Clears Biodefense Bill

The Senate Dec. 5 passed the Pandemic and All-Hazards Preparedness Act (S. 3678). The bill creates the Biomedical Advanced Research and Development Authority (BARDA) within the Department of Health and Human Services (HHS). BARDA is designed to improve upon Project Bioshield by coordinating all federal research and development of bioterrorism countermeasures. It also reauthorizes the existing bioterrorism law (P.L. 107-188).

S. 3678 also returns the National Disaster Medical System (NDMS) to HHS from the Department of Homeland Security and includes an EMTALA waiver, which allows for the transfer of individuals from hospitals during an emergency involving a pandemic infectious disease. The bill also creates partnerships for state and regional hospital preparedness to improve surge capacity and allows the HHS Secretary to reserve an amount from the existing Bioterrorism Hospital Preparedness program for these partnerships.

The House Sept. 26 passed a biodefense bill (H.R. 5533) that includes the creation of BARDA but not the reauthorization provisions [see Washington Highlights, Sept. 29]. Additionally, the Senate bill authorizes $1.1 billion for advanced research and development over fiscal years 2007 and 2008, while the House bill authorizes $320 million over those years. It is unclear if the House will pass S. 3678 before it adjourns.

Information:
Erica Froyd, Director, Public Health and Research Legislative Affairs
AAMC Government Relations
efroyd@aamc.org
(202) 828-0525

House Extends Physician Visa Waivers

The House Dec. 6 passed the "Physicians for Underserved Areas Act" (H.R. 4997) to reauthorize J-1 visa waiver programs through 2008. These waiver programs exempt foreign physicians who receive their graduate medical education in the U.S. from the 2-year home service requirement of the J-1 visa in exchange for practicing in a health professions shortage area. Participating entities include the Department of Health and Human Services, the Mississippi Delta Regional Authority, the Appalachian Regional Commission, and the State Departments of Health "Conrad 30" program.

Corresponding legislation (S. 2425) was introduced March 15 by Sens. Kent Conrad (D.-N.D.) and Sam Brownback (R-Kan.). The senators are pushing for a vote on H.R. 4997 before Congress adjourns.

Information:
Matthew Shick, Senior Legislative Analyst
AAMC Government Relations
mshick@aamc.org
(202) 862-6116

Senate Passes Ryan White

After weeks of being stalled by New York and New Jersey lawmakers, the Senate Dec. 6 passed by voice vote a bill (H.R. 6143) to reauthorize the Ryan White CARE Act (P.L. 106-345). Sens. Hillary Clinton (D-N.Y.), Charles Schumer (D-N.Y.), Frank Lautenberg (D-N.J.) and Robert Menendez (D-N.J.) lifted their block on the measure after ranking member of the Senate Health, Education, Labor and Pensions Committee Sen. Edward Kennedy (D-Mass.) negotiated a compromise to mitigate the expected funding losses to urban states.

Under the compromise, the program will be reauthorized for 3 years instead of 5, as originally intended in the House-passed bill. Additionally, the law will be completely repealed in 3 years, requiring a new law to be written in accordance with a comprehensive reevaluation of the program's structure. The amended bill also includes a provision that maintains funds for Title I and Title II at a minimum of 95 percent of the FY 2006 levels for each state.

The House Sept. 26 passed its version of the bill, but it is unclear whether the House will consider the amended bill before adjournment [see Washington Highlights, Sept. 29].

Information:
Tannaz Rasouli, Senior Legislative Analyst
AAMC Government Relations
trasouli@aamc.org
(202) 828-0525

JCAHO Releases Patient Level Data Collection Policy

The Joint Commission on Accreditation of Health Care Organizations (JCAHO) Nov. 27 released its new patient level data collection policy. The new policy is aimed at improving the validity and reliability of the data collected through its core measure program, which is the same process that collects the data submitted to the Centers for Medicare and Medicaid Services (CMS) for the hospital pay for reporting program. Prior to the release, JCAHO held eight months of meetings with hospitals across the country to address concerns raised when the proposal was announced earlier this year.

Previously, JCAHO received aggregate hospital data including a random sample of patient level data for 20 percent of the relevant cases for each measure. Beginning with second quarter 2007 discharges, JCAHO will continue to receive the aggregate hospital data but also will receive a 100 percent patient sample for the relevant cases for each performance measure. This first set of data is due to be reported by Oct. 31, 2007.

The data will not contain any hospital specific identifiers or any patient specific identifiers such as name or Social Security number. The patient specific data will remain in the possession of the vendors, who will be responsible for stripping the data and providing a file to the JCAHO that only contains a randomly generated identifier for tracking purposes in case there are data inconsistencies. By collecting the patient level data, JCAHO will be in a better position to audit the data consistently and identify any inconsistencies that could affect a hospital's performance rating.

The new policy will not change the way the hospitals submit data to their vendor and should be a seamless change. However, vendors may look to charge hospitals a small one-time fee to accommodate the new submission requirements.

Information:
Jennifer Faerberg, AAMC Division of Health Care Affairs
Director, GME Track/Health Care Quality Liaison
jfaerberg@aamc.org
(202) 862-6221

NIH Director Discusses "Post-Doubling" Era

National Institutes of Health (NIH) Director Elias Zerhouni, M.D., Dec. 1 presented his analysis of the fiscal and programmatic constraints faced by the agency nearly four years after completion of the agency's budget doubling at a meeting of the Advisory Committee to the Director (ACD). Dr. Zerhouni's analysis, published in the Nov. 16 issue of Science, resumes the ACD's deliberations on this topic begun at the June 2 meeting [see Washington Highlights, June 9].

Dr. Zerhouni noted that the limited growth in NIH appropriations since 2003, the effects of inflation, a continuing increase in numbers of new applications, and a backlog of prior commitments have combined to make the current funding environment extremely difficult for scientists seeking funding for their research proposals. He reported that overall success rates for award of NIH research project grants are about 20 percent, and 17 percent for new applications.

ACD member Tadataka Yamada, M.D., newly appointed President of the Gates Foundation Global Health Program, described the issue as a "supply-demand" problem, and suggested that NIH ask the National Academies to help develop a plan for better balancing the supply of scientists with foreseeable resources. Committee member David Botstein, Ph.D., of Princeton University criticized universities' over-expansion of infrastructure, based on unrealistic expectations for NIH to finance the new capacity. Karen Holbrook, Ph.D., President of Ohio State University and a new member to the ACD, defended the "deans'" decisions as necessary to modernize outdated facilities and meet the technological requirements of cutting-edge science.

The ACD was particularly concerned that fewer than 10 percent of un-amended R01 applications are funded on their first try, and suggested ways NIH might shorten the cycle leading to first award. In later discussions, the committee strongly endorsed efforts to streamline or simplify regulations on investigators and institutions, which they note create a significant burden on institutional resources.

NIH's plans to switch to electronic grant submission for most major award mechanisms in February initiated much discussion. The ACD remains concerned that investigators are not fully briefed about new procedures, and urged NIH to communicate more information clarifying the e-application requirements to help institutions better prepare for the switch. The NIH leadership noted that the change is required by federal mandate, but agreed to work for better communication. Dr. Zerhouni also proposed creation of a "users group" of ACD members to identify early problems in electronic submission.

Information:
Stephen Heinig, Lead Science Policy Analyst
AAMC Biomedical Health Sciences Research
sheinig@aamc.org
(202) 828-0488

CMS Updates PPAC on Quality Reporting, Cost Measurement

At the Dec. 4 meeting of Physician Payment Advisory Commission (PPAC), Tom Valuck, M.D., J.D., of the Centers of Medicare and Medicaid Services (CMS), presented an update on the agency's initiatives on quality reporting and cost measurement. CMS is distributing the first set of confidential performance reports to physicians participating in the Physician Voluntary Reporting Program (PVRP). The PVRP is a voluntary program where physicians report quality indicators through adding special codes to Medicare claims. CMS plans to expand it in 2007 from the current 16 measures to 66 measures.

CMS also is working with its contractor to evaluate the feasibility of a commercial episode grouper regarding cost and efficiency measures. CMS's goal is to "develop meaningful, actionable, and fair" cost measurements and to link those measurements to quality.

In addition, CMS presented the 2006 findings of the initial Medicare Contractor Provider Satisfaction Survey. The average composite score for carriers was 4.52 on a 6-point scale. The most important predictors of satisfaction were the handling of inquiries and claims. The 2007 survey will run from January through April, and will add new satisfaction metrics and questions on the National Provider Identifier (NPI).

Other topics addressed in the meeting include:

  • Updates on Physicians Regulatory Issues Team (PRIT) activities;
  • 2006 findings of the Recovery Audit Contractors (RAC) demonstration; and
  • Highlights of the 2007 physician fee schedule and other payment systems.

Information:
Denise Dodero, Sr. Director, Health Care Affairs
AAMC Health Care Affairs
ddodero@aamc.org
(202) 828-0493

Mary Patton, Senior Specialist
AAMC Health Care Affairs
mpatton@aamc.org
(202) 862-6297

Senate Confirms FDA Head

The Senate Dec. 7 voted 80-11 to confirm Andrew C. von Eschenbach, M.D. as commissioner of the Food and Drug Administration (FDA). Originally nominated for the position in March, von Eschenbach has been serving as acting commissioner since September 2005. For part of that time, von Eschenbach also led the National Cancer Institute (NCI) where he was director since January 2002, until leaving to head the FDA full time in June. The president appointed John E. Niederhuber, M.D., director of NCI in August [see Washington Highlights, Sept. 1].

Prior to his appointment at NCI, von Eschenbach was Executive Vice President and Chief Academic Officer of the University of Texas M.D. Anderson Cancer Center in Houston, where he also served as Vice President for Academic Affairs and held the Roy M. and Phyllis Gough Huffington Clinical Research Distinguished Chair in Urologic Oncology.

A graduate of St. Joseph's University in Philadelphia, von Eschenbach received his medical degree from Georgetown University School of Medicine. He completed internship at Philadelphia General Hospital and residency in urologic surgery at Pennsylvania Hospital in Philadelphia before serving as an instructor in urology at the University of Pennsylvania School of Medicine.